159 related articles for article (PubMed ID: 30597308)
21. METTL3 attenuates proliferative vitreoretinopathy and epithelial-mesenchymal transition of retinal pigment epithelial cells via wnt/β-catenin pathway.
Ma X; Long C; Wang F; Lou B; Yuan M; Duan F; Yang Y; Li J; Qian X; Zeng J; Lin S; Shen H; Lin X
J Cell Mol Med; 2021 May; 25(9):4220-4234. PubMed ID: 33759344
[TBL] [Abstract][Full Text] [Related]
22. PDGFRβ plays an essential role in patient vitreous-stimulated contraction of retinal pigment epithelial cells from epiretinal membranes.
Yang Y; Huang X; Ma G; Cui J; Matsubara JA; Kazlauskas A; Zhao J; Wang J; Lei H
Exp Eye Res; 2020 Aug; 197():108116. PubMed ID: 32561481
[TBL] [Abstract][Full Text] [Related]
23. [Pathomorphology of membranes appearing in proliferative vitreoretinopathies].
Laudańska-Olszewska I; Omulecki W; Dziegielewski K; Pikulski Z; Omulecka A
Klin Oczna; 2006; 108(1-3):28-31. PubMed ID: 16883935
[TBL] [Abstract][Full Text] [Related]
24. Effect of Robo1 on retinal pigment epithelial cells and experimental proliferative vitreoretinopathy.
Huang L; Xu Y; Yu W; Li Y; Chu L; Dong J; Li X
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3193-204. PubMed ID: 20071679
[TBL] [Abstract][Full Text] [Related]
25. The role of thrombin in proliferative vitreoretinopathy.
Bastiaans J; van Meurs JC; Mulder VC; Nagtzaam NM; Smits-te Nijenhuis M; Dufour-van den Goorbergh DC; van Hagen PM; Hooijkaas H; Dik WA
Invest Ophthalmol Vis Sci; 2014 Jul; 55(7):4659-66. PubMed ID: 25015355
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the Effect of Everolimus on Retinal Pigment Epithelial Cells and Experimental Proliferative Vitreoretinopathy.
Kuo HK; Chen YH; Kuo YH; Ke MC; Tseng YC; Wu PC
Curr Eye Res; 2018 Mar; 43(3):333-339. PubMed ID: 29182404
[TBL] [Abstract][Full Text] [Related]
27. Apoptosis and cell proliferation in proliferative retinal disorders: PCNA, Ki-67, caspase-3, and PARP expression.
Zhang X; Barile G; Chang S; Hays A; Pachydaki S; Schiff W; Sparrow J
Curr Eye Res; 2005 May; 30(5):395-403. PubMed ID: 16020270
[TBL] [Abstract][Full Text] [Related]
28. Assessment of the integrin alpha5beta1 antagonist JSM6427 in proliferative vitreoretinopathy using in vitro assays and a rabbit model of retinal detachment.
Zahn G; Volk K; Lewis GP; Vossmeyer D; Stragies R; Heier JS; Daniel PE; Adamis AP; Chapin EA; Fisher SK; Holz FG; Löffler KU; Knolle J
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1028-35. PubMed ID: 19815730
[TBL] [Abstract][Full Text] [Related]
29. Diverse NF-kappaB expression in epiretinal membranes after human diabetic retinopathy and proliferative vitreoretinopathy.
Harada C; Harada T; Mitamura Y; Quah HM; Ohtsuka K; Kotake S; Ohno S; Wada K; Takeuchi S; Tanaka K
Mol Vis; 2004 Jan; 10():31-6. PubMed ID: 14737065
[TBL] [Abstract][Full Text] [Related]
30. Resveratrol inhibits epithelial-mesenchymal transition of retinal pigment epithelium and development of proliferative vitreoretinopathy.
Ishikawa K; He S; Terasaki H; Nazari H; Zhang H; Spee C; Kannan R; Hinton DR
Sci Rep; 2015 Nov; 5():16386. PubMed ID: 26552368
[TBL] [Abstract][Full Text] [Related]
31. Effects of Curcumin on Epidermal Growth Factor in Proliferative Vitreoretinopathy.
Ren YX; Ma JX; Zhao F; An JB; Geng YX; Liu LY
Cell Physiol Biochem; 2018; 47(5):2136-2146. PubMed ID: 29975931
[TBL] [Abstract][Full Text] [Related]
32. Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells.
Casaroli-Marano RP; Pagan R; Vilaró S
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2062-72. PubMed ID: 10440262
[TBL] [Abstract][Full Text] [Related]
33. Overexpression p21WAF1/CIP1 in suppressing retinal pigment epithelial cells and progression of proliferative vitreoretinopathy via inhibition CDK2 and cyclin E.
Wang Y; Yuan Z; You C; Han J; Li H; Zhang Z; Yan H
BMC Ophthalmol; 2014 Nov; 14():144. PubMed ID: 25421815
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical study of angiogenesis and proliferative activity in epiretinal membranes.
Tsanou E; Ioachim E; Stefaniotou M; Gorezis S; Charalabopoulos K; Bagli H; Peschos D; Psilas K; Agnantis NJ
Int J Clin Pract; 2005 Oct; 59(10):1157-61. PubMed ID: 16178982
[TBL] [Abstract][Full Text] [Related]
35. The effects of pleiotrophin in proliferative vitreoretinopathy.
Ding X; Bai Y; Zhu X; Li T; Jin E; Huang L; Yu W; Zhao M
Graefes Arch Clin Exp Ophthalmol; 2017 May; 255(5):873-884. PubMed ID: 28083679
[TBL] [Abstract][Full Text] [Related]
36. Development of Proliferative Vitreoretinopathy Is Attenuated by Chicken Ovalbumin Upstream Promoter Transcriptional Factor 1 Via Inhibiting Epithelial-Mesenchymal Transition.
Jin H; Cai W; Yu D; Fan J; Liu Q; Yu J
Discov Med; 2022; 34(172):103-113. PubMed ID: 36333112
[TBL] [Abstract][Full Text] [Related]
37. Introduction of the MDM2 T309G Mutation in Primary Human Retinal Epithelial Cells Enhances Experimental Proliferative Vitreoretinopathy.
Zhou G; Duan Y; Ma G; Wu W; Hu Z; Chen N; Chee Y; Cui J; Samad A; Matsubara JA; Mukai S; D'Amore PA; Lei H
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5361-5367. PubMed ID: 29049737
[TBL] [Abstract][Full Text] [Related]
38. Protective Effects of Fucoidan on Epithelial-Mesenchymal Transition of Retinal Pigment Epithelial Cells and Progression of Proliferative Vitreoretinopathy.
Zhang Y; Zhao D; Yang S; Yao H; Li M; Zhao C; Zhang J; Xu GT; Li H; Wang F
Cell Physiol Biochem; 2018; 46(4):1704-1715. PubMed ID: 29698960
[TBL] [Abstract][Full Text] [Related]
39. PDGF receptors are activated in human epiretinal membranes.
Cui J; Lei H; Samad A; Basavanthappa S; Maberley D; Matsubara J; Kazlauskas A
Exp Eye Res; 2009 Mar; 88(3):438-44. PubMed ID: 19032953
[TBL] [Abstract][Full Text] [Related]
40. Idelalisib inhibits vitreous-induced Akt activation and proliferation of retinal pigment epithelial cells from epiretinal membranes.
Xin T; Han H; Wu W; Huang X; Cui J; Matsubara JA; Song J; Wang F; Colyer M; Lei H
Exp Eye Res; 2020 Jan; 190():107884. PubMed ID: 31786159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]